Mylan weighs move for Swedish rival Meda

[at Financial Times] – Mylan Inc, the US generic drug producer, is eyeing the takeover of Swedish rival Meda in a deal that would create a $23bn-plus pharmaceutical business as the US healthcare industry goes through one of … more

View todays social media effects on MYL

View the latest stocks trending across Twitter. Click to view dashboard

See who Mylan is hiring next, click here to view